Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial-Mesenchymal Transition. | Int J Mol Sci | 2023 | 37239838 | PubTator, text mining | PubMed |
| Unanticipated broad phylogeny of BEN DNA-binding domains revealed by structural homology searches. | Curr Biol | 2023 | 37236184 | PubTator, text mining | PubMed |
| Transporter proteins knowledge graph construction and its application in drug development. | Comput Struct Biotechnol J | 2023 | 37235186 | PubTator, text mining | PubMed |
| Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial. | Clin Cancer Res | 2023 | 37227187 | PubTator, text mining | PubMed |
| Differential effect of panic on the DNA methylation of the glucocorticoid receptor gene exon 1F in chronic subjective tinnitus with distress. | Psychiatr Genet | 2023 | 37222222 | PubTator, text mining | PubMed |
| Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication. | Mol Cancer Ther | 2023 | 37216280 | PubTator, text mining | PubMed |
| Single Inhibitors versus Dual Inhibitors: Role of HDAC in Cancer. | ACS Omega | 2023 | 37214715 | PubTator, text mining | PubMed |
| DNA supercoiling restricts the transcriptional bursting of neighboring eukaryotic genes. | Mol Cell | 2023 | 37207624 | PubTator, text mining | PubMed |
| MUS81 cleaves TOP1-derived lesions and other DNA-protein cross-links. | BMC Biol | 2023 | 37194054 | PubTator, text mining | PubMed |
| Multi-Receptive Field Soft Attention Part Learning for Vehicle Re-Identification. | Entropy (Basel) | 2023 | 37190382 | PubTator, text mining | PubMed |
| Circular RNA Expression Profiling by Microarray-A Technical and Practical Perspective. | Biomolecules | 2023 | 37189426 | PubTator, text mining | PubMed |
| Identification of multidentate tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors that simultaneously access the DNA, protein and catalytic-binding sites by oxime diversification. | RSC Chem Biol | 2023 | 37181631 | PubTator, text mining | PubMed |
| Re-Evaluation Method by Index Finger Position in the Face Area Using Face Part Position Criterion for Sign Language Recognition. | Sensors (Basel) | 2023 | 37177525 | PubTator, text mining | PubMed |
| In Vitro and In Vivo Therapeutic Potential of 6,6'-Dihydroxythiobinupharidine (DTBN) from Nuphar lutea on Cells and K18-hACE2 Mice Infected with SARS-CoV-2. | Int J Mol Sci | 2023 | 37176034 | PubTator, text mining | PubMed |
| Cytotoxic Activity, Topoisomerase I Inhibition and In Silico Studies of New Sesquiterpene-aryl Ester Derivatives of (-) Drimenol. | Molecules | 2023 | 37175368 | PubTator, text mining | PubMed |
| Thieno-Thiazolostilbenes, Thienobenzo-Thiazoles, and Naphtho-Oxazoles: Computational Study and Cholinesterase Inhibitory Activity. | Molecules | 2023 | 37175190 | PubTator, text mining | PubMed |
| MSRDL: Deep learning framework for service recommendation in mashup creation. | Sci Rep | 2023 | 37169772 | PubTator, text mining | PubMed |
| Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade. | J Immunother Cancer | 2023 | 37156551 | PubTator, text mining | PubMed |
| Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer. | World J Gastroenterol | 2023 | 37155531 | PubTator, text mining | PubMed |
| Ubx5-Cdc48 assists the protease Wss1 at DNA-protein crosslink sites in yeast. | EMBO J | 2023 | 37144685 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=30